Epidermolytic hyperkeratosis: A keratin 1 or 10 mutational event

International Journal of Dermatology

Volumn 44, Issue 1, 2005, Pages 1-6

  Lacz, Nicole L ^a   Schwartz, Robert A ^a   Kihiczak, George ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ANTIBIOTIC AGENT; EMOLLIENT AGENT; ETRETINATE; HYDROXYACID; KERATIN; KERATIN 10; KERATIN TYPE 1; POLYHYDROXY ACID; RETINOIC ACID; RETINOID; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; BLISTER; CLINICAL FEATURE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; ERYTHEMA; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; KERATINIZATION; MUTATIONAL ANALYSIS; PATHOGENESIS; PENETRANCE; PHENOTYPE; REVIEW; SEPSIS; SKIN ABRASION; SPONTANEOUS MUTATION; SYMPTOMATOLOGY;

DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; GENES, DOMINANT; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; KERATIN-1; KERATIN-10; KERATINS; MUTATION; PHENOTYPE;

EID: 13444279113     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02364.x     Document Type: Review

References (62)

1. Nikolski P. Contribution à l'ètude des anomalies congènitales de keratinisation. Comptes-Rèndus XII Congres Int Medicine, Moscuo 1897; IV: 433-442.
2. Brocq L. Erythrodermie congénitale ichthyosiforme avec hyperépidermotrophie. Ann Derm Syphiligr 1902; 3: 1-31.
3. Frost P, Van Scott EJ. Ichthyosiform dermatoses. Classification based on anatomic and biometric observation. Arch Dermatol 1966; 94: 113-126.
4. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130: 1026-1035.
5. Ammirati CT, Mallory SB. The major inherited disorders of cornification. Dermatol Clin 1998; 16: 497-508.
6. Williams ML, Elias PM. Genetically transmitted, generalized disorders of cornification. The ichthyoses. Dermatol Clin 1987; 5: 155-178.
7. Bichenbach JR, Longley MA, Cundman DS, et al. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Differentiation 1996; 61: 129-139.
8. Sprecher E, Yosipovitch G, Bergman R, et al. Epidermolytic hyperkeratosis and epidermolysis bullosa simplex caused by frameshift mutations altering the V2 tail domains of keratin 1 and keratin 5. J Invest Dermatol 2003; 120: 623-626.
9. Anton-Lamprecht I. Genetically induced abnormalities of epidermal differentiation and ultrastructure in ichthyoses and epidermolyses: pathogenesis, heterogeneity, fetal manifestation, and prenatal diagnosis. J Invest Dermatol 1983; 81: 149s-156s.
10. Yang JM, Yoneda K, Morita E, et al. An alanine to proline mutation in the 1A rod domain of the keratin to chain in epidermolytic hyperkeratosis. J Invest Dermatol 1997; 109: 692-694.
11. Arin MJ, Longley MA, Epstein EH Jr, et al. Identification of a novel mutation in keratin 1 in a family with epidermolytic hyperkeratosis. Exp Dermatol 2000; 9: 16-19.
12. Chipev CC, Steinert PM, Woodworth CD. Characterization of an immortalized cell line from a patient with epidermolytic hyperkeratosis. J Invest Dermatol 1996; 106: 385-390.
13. Sun XK, Ma LL, Xie YQ, et al. Keratin 1 and 10 mutations causing epidermolytic hyperkeratosis in Chinese patients. J Dermatol Sci 2002; 29: 195-200.
14. Saeki H, Hattori N, Mitsui H, et al. A keratin 10 gene mutation (Arg156Cys) in a Japanese patient with bullous congenital ichthyosiform erythroderma. J Dermatol 2002; 29: 168-171.
15. Mayuzumi N, Shigihara T, Ikeda S, et al. Recurrent R156H mutation of KRT10 in a Japanese family with bullous congenital ichthyosiform erthyroderma. J Eur Acad Dermatol Venereol 2002; 14: 304-306.
16. Yang JM, Nam K, Kim SW, et al. Arginine in the beginning of the 1A rod domain of the keratin 10 gene is the hot spot for the mutation in epidermolytic hyperkeratosis. J Dermatol Sci 1999; 19: 126-133.
17. Yang JM, Nam K, Kim HC, et al. A novel glutamic acid to aspartic acid mutation near the end of the 2B rod domain in the keratin 1 chain in epidermolytic hyperkeratosis. J Invest Dermatol 1999; 112: 376-379.
18. Smith F. The molecular genetics of keratin disorders. Am J Clin Dermatol 2003; 4: 347-364.
19. Porter RM, Lane EB. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 2003; 19: 278-285.
20. Ishida-Yamamoto A, Takahashi H, Iizuka H. Lessons from disorders of epidermal differentiation-associated keratins. Histol Histopathol 2002; 17: 331-338.
21. Schmuth M, Yosipovitch G, Williams ML, et al. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 2001; 117: 837-847.
22. Reichelt J, Doering T, Schnetz E, et al. Normal ultrastructure, but altered stratum corneum lipid and protein composition, in a mouse model for epidermolytic hyperkeratosis. J Invest Dermatol 1999; 113: 329-334.
23. Arin MJ, Longley MA, Anton-Lamprecht I, et al. A novel substitution in keratin 10 in epidermolytic hyperkeratosis. J Invest Dermatol 1999; 112: 506-508.
24. Otley C, Gellis S. Epidermolytic hyperkeratosis. Int J Dermatol 1996; 35: 579-581.
25. Liovic M, Stojan J, Bowden PE, et al. A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes. J Invest Dermatol 2001; 116: 964-969.
26. Reddy BSN, Thadeus J, Kumar SKA, et al. Generalized epidermolytic hyperkeratosis in a child born to a parent with systematized epidermolytic linear epidermal nevus. Int J Dermatol 1997; 36: 198-200.
27. Nomura K, Umeki K, Hatayama I, et al. Phenotypic heterogeneity in bullous congenital ichthyosiform erythroderma: possible somatic mosaicism for keratin gene mutation in the mildly affected mother of the proband. Arch Dermatol 2001; 137: 1192-1195.
28. Paller AS. Expanding our concepts of mosaic disorders of skin. Arch Dermatol 2001; 137: 1236-1238.
29. Kumar S, Sehgal VN, Sharma RC. Epidermolytic hyperkeratosis. Int J Dermatol 1999; 38: 914-915.
30. Stowell JC, Stone MS. Answers to self-assessment examination of the American Academy of Dermatology identification no. 800-201. J Am Acad Dermatol 2000; 42: 155-156.
31. Au WY, Ma SY, Yeung CK, et al. A patient with congenital ichthyosis hystrix (disseminated congenital nevus) and acute lymphoblastic leukemia. Leuk Lymphoma 2003; 44: 209-212.
32. Palmer AK, Louis DS. Flexion contractures of the hand associated with ichthyosis hystrix. Case report. J Bone Joint Surg Am 1976; 58: 143-144.
33. Stratigos J, Tsambaos D. Ichthyosis hystrix and skin cancer. Clin Exp Dermatol 1994; 20: 85-86.
34. Capetanakis J, Stratigos J, Tsambaos D, et al. Ichthyosis hystrix of "porcupine man" type. Dermatologica 1975; 151: 177-183.
35. Conlin PA, Rapini RP. Epidermolytic hyperkeratosis associated with melanocytic nevi: a report of 53 cases. Am J Dermatopathol 2002; 24: 23-25.
36. Niemi KM, Virtanen I, Kanerva L, et al. Altered keratin expression in ichthyosis hystrix Curth-Macklin. A light and electron microscopic study. Arch Dermatol Res 1990; 282: 227-233.
37. Cserhalmi-Friedman PB, Squeo R, Gordon D, et al. Epidermolytic hyperkeratosis in a Hispanic family resulting from a mutation in the keratin 1 gene. Clin Exp Dermatol 2000; 25: 141-243.
38. Baleviciené G, Schwartz RA. Epidermolytic hyperkeratosis with ichthyosis hystrix. Cutis 2000; 66: 319-322.
39. Kremer H, Lavrijsen APM, McLean WHI, et al. An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1. J Invest Dermatol 1998; 111: 1224-1226.
40. Rothnagel JA, Lin MTS, Longley MA, et al. Prenatal diagnosis for keratin mutations to exclude transmission of epidermolytic hyperkeratosis. Prenat Diagn 1998; 18: 826-830.
41. Pulkkinen L, Ringpfeil F, Uitto J. Progress in heritable skin diseases: molecular bases and clinical implications. J Am Acad Dermatol 2002; 47: 91-104.
42. Kansky A, Stanimirovic A, Basta-Juzbasic A. Isolated cases of palmoplantar keratoderma, Unna-Thost type. Cutis 1992; 49: 406-408.
43. Kansky A, Arzensek J, Rode M, et al. Keratoderma palmoplantaris of the Unna-Thost type in Slovenia. Acta Derm Venereol (Stockh) 1984; 64: 140-143.
44. Kansky A, Durinovic-Bello I, de Jongh BM, et al. HLA antigens in Yugoslav patients with palmoplantar keratoderma, type Unna-Thost: a family study. Acta Derm Venereol (Stockh) 1982; 62 313-316.
45. Irvine AD, McLean WH. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999; 140: 815-828.
46. Hatsell SJ, Kelsell DP. The diffuse palmoplantar keratodermas. Acta Derm Venereol (Ljubljana) 2000; 9: 47-54.
47. Kansky A, Arzensek J. Is palmoplantar keratoderma of Greither's type a separate nosologic entity? Dermatologica 1979; 158: 244-248.
48. Minutilli E, Mastroianni A, Berardesca E, et al. Inherited diffuse epidermolytic palmoplantar keratoderma: clinical, histopathogic, ultrastructural and genetic aspects. Esper Dermatol (Roma) 2003; 5: 17-24.
49. Ishida-Yamamoto A, Richard G, Takahashi H, et al. In vivo studies of mutant keratin 1 in ichthyosis hystrix Curth-Macklin type. J Invest Dermatol 2003; 120: 498-500.
50. Arnold ML, Anton-Lamprecht I, Albrecht-Nebe H. Congenital ichthyosis with hypogonadism and growth retardation - a new syndrome with peculiar ultrastructutal features. Arch Dermatol Res 1992; 284 198-208.
51. Kanerva L, Karvonen J, Oikarinen A, et al. Ichthyosis hystrix (Curth-Macklin) - light and electron microscopic studies performed before and after etretinate treatment. Arch Dermatol 1984; 120: 1218-1223.
52. Sprecher E, Ishida-Yamamoto A, Becker OM, et al. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001; 116: 511-519.
53. Kriner J, Montes LF. Gigantic ichthyosis hystrix. J Am Acad Dermatol 1997; 36: 646-647.
54. Basler RSW, Jacobs SI, Taylor WB. Ichthyosis hystrix. Arch Dermatol 1978; 114: 1059-1060.
55. Allen BR. Ichthyosis hystrix. Br J Dermatol 1978; 99 26.
56. Ahsan H, Chen Y, Wang Q, et al. DNA repair gene XPD and susceptibility to arsenic-induced hyperkeratosis. Toxicol Lett 2003; 143: 123-131.
57. Schwartz RA. Arsenic and the skin. Int J Dermatol 1997; 36: 241-250.
58. Kempers S, Katz HI, Wildnauer R, et al. An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of moderate to severe xerosis, epidermolytic hyperkeratosis, and ichthyosis. Cutis 1998; 61: 347-350.
59. Nychay SG, Khorenian SD, Schwartz RA, et al. Epidermolytic hyperkeratosis treated with etretinate. Cutis 1991; 47: 277-280.
60. Kansky A, Podrumac B, Prelog I. Hereditary ichthyosis. Pathogenesis and possibilities of treatment. Acta Derm Venereol (Ljubljana) 1997; 6: 47-54.
61. Happle R. Retinoids in disorders of keratinization: their use in adults. Dermatologica 1987; 175: 107-124.
62. Virtanen M, Gedde-Dahl T Jr, Mork NJ, et al. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol (Stockh) 2001; 81: 163-170.